GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnGes Inc (TSE:4563) » Definitions » Policy Acquisition Expense

AnGes (TSE:4563) Policy Acquisition Expense


View and export this data going back to 2002. Start your Free Trial

What is AnGes Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


AnGes Business Description

Industry
Traded in Other Exchanges
N/A
Address
7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.